Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II trial of oral etoposide plus intravenous irinotecan in patients with platinum-resistant and taxane-pretreated ovarian cancer (JCOG0503)

Published:2015-02 Issue:2 Volume:136 Page:218-223
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Matsumoto Koji,Katsumata Noriyuki,Shibata Taro,Satoh Toyomi,Saitou Motoaki,Yunokawa Mayu,Takano Tadao,Nakamura Kenichi,Kamura Toshiharu,Konishi Ikuo

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference30 articles.

1. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III trial of the Gynecologic Cancer Intergroup;Bookman;J Clin Oncol,2009

2. Dose-dense paclitaxel once a week in combination with carboplatin every 3weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial;Katsumata;Lancet,2009

3. Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan;Gordon;J Clin Oncol,2001

4. Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer;Mutch;J Clin Oncol,2007

5. Combined inhibition of topoisomerases I and II—is this a worthwhile/feasible strategy?;Vasey;Br J Cancer,1997

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Stable Irinotecan Liposome with Enhanced Antitumor Activity in a Range of Tumor Models;Pharmaceutical Research;2023-11-01

2. A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?;Frontiers in Pharmacology;2023-10-26

3. Venous Thromboembolism in Cancer Patients Undergoing Chemotherapy: A Systematic Review and Meta-Analysis;Diagnostics;2022-11-25

4. Effectiveness of low-dose oral etoposide treatment in patients with recurrent and platinum-resistant epithelial ovarian cancer;Journal of Obstetrics and Gynaecology;2017-03-21

5. Treatment of Recurrent Epithelial Ovarian Cancer;Comprehensive Gynecology and Obstetrics;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3